Search research articles
Contact Us
Filters
Showing results (31-40 of 154) with videos related to
Page
of 16
Sort By:
Thorax
|
October 8, 2025
Top 10 research priorities for pulmonary fibrosis in Australia: an update
Gabriella Tikellis, Tamera J Corte, Alison J Hey-Cunningham, et al.
Journal of Clinical Medicine
|
May 5, 2017
Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF)
Adelle S Jee, Stephen Adelstein, Jane Bleasel, et al.
Respirology (Carlton, Vic.)
|
November 6, 2022
Clinical utility of a standardized chronic hypersensitivity pneumonitis exposure questionnaire
Hayley Barnes, Daniel Chambers, Chris Grainge, et al.
Expert Review of Respiratory Medicine
|
September 26, 2018
Safe and effective exercise training for patients with pulmonary arterial hypertension: putting current evidence into clinical practice
Melanie Lavender, Karen Sw Chia, Nathan Dwyer, et al.
Frontiers in Medicine
|
July 5, 2022
Efficacy of Pirfenidone vs. Placebo in Unclassifiable Interstitial Lung Disease, by Surgical Lung Biopsy Status: Data From a <i>post-hoc</i> Analysis
Maria Molina-Molina, Michael Kreuter, Vincent Cottin, et al.
ERJ Open Research
|
November 11, 2021
Nailfold capillaroscopy by smartphone-dermatoscope for connective tissue disease diagnosis in interstitial lung disease: a prospective observational study
Adelle S Jee, Matthew J S Parker, Neil McGill, et al.
Advances in Therapy
|
December 22, 2021
Pirfenidone in Unclassifiable Interstitial Lung Disease: A Subgroup Analysis by Concomitant Mycophenolate Mofetil and/or Previous Corticosteroid Use
Michael Kreuter, Toby M Maher, Tamera J Corte, et al.
BMJ Open Respiratory Research
|
December 25, 2025
Design of the MIST study: a double-blind, randomised, placebo-controlled phase 2b trial of pirfenidone solution for inhalation in patients with progressive pulmonary fibrosis
Martin Kolb, Tamera J Corte, Jeremy Feldman, et al.
Heart, Lung & Circulation
|
May 15, 2017
The Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Cardiac Sarcoidosis
Kelly M Stanton, Madhusudan Ganigara, Peter Corte, et al.
Respiratory Medicine
|
February 15, 2025
Geographic variability of interstitial lung disease diagnoses and impact of air pollution on disease outcomes
Annalise Bagust, Cheng Zhao, Lauren Troy, et al.
Page
of 16
Search research articles
Search
Showing results (31-40 of 154) with videos related to
Sort By:
Page
of 16
Thorax
|
October 8, 2025
Top 10 research priorities for pulmonary fibrosis in Australia: an update
Gabriella Tikellis, Tamera J Corte, Alison J Hey-Cunningham, et al.
Journal of Clinical Medicine
|
May 5, 2017
Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF)
Adelle S Jee, Stephen Adelstein, Jane Bleasel, et al.
Respirology (Carlton, Vic.)
|
November 6, 2022
Clinical utility of a standardized chronic hypersensitivity pneumonitis exposure questionnaire
Hayley Barnes, Daniel Chambers, Chris Grainge, et al.
Expert Review of Respiratory Medicine
|
September 26, 2018
Safe and effective exercise training for patients with pulmonary arterial hypertension: putting current evidence into clinical practice
Melanie Lavender, Karen Sw Chia, Nathan Dwyer, et al.
Frontiers in Medicine
|
July 5, 2022
Efficacy of Pirfenidone vs. Placebo in Unclassifiable Interstitial Lung Disease, by Surgical Lung Biopsy Status: Data From a <i>post-hoc</i> Analysis
Maria Molina-Molina, Michael Kreuter, Vincent Cottin, et al.
ERJ Open Research
|
November 11, 2021
Nailfold capillaroscopy by smartphone-dermatoscope for connective tissue disease diagnosis in interstitial lung disease: a prospective observational study
Adelle S Jee, Matthew J S Parker, Neil McGill, et al.
Advances in Therapy
|
December 22, 2021
Pirfenidone in Unclassifiable Interstitial Lung Disease: A Subgroup Analysis by Concomitant Mycophenolate Mofetil and/or Previous Corticosteroid Use
Michael Kreuter, Toby M Maher, Tamera J Corte, et al.
BMJ Open Respiratory Research
|
December 25, 2025
Design of the MIST study: a double-blind, randomised, placebo-controlled phase 2b trial of pirfenidone solution for inhalation in patients with progressive pulmonary fibrosis
Martin Kolb, Tamera J Corte, Jeremy Feldman, et al.
Heart, Lung & Circulation
|
May 15, 2017
The Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Cardiac Sarcoidosis
Kelly M Stanton, Madhusudan Ganigara, Peter Corte, et al.
Respiratory Medicine
|
February 15, 2025
Geographic variability of interstitial lung disease diagnoses and impact of air pollution on disease outcomes
Annalise Bagust, Cheng Zhao, Lauren Troy, et al.
Page
of 16